BE Study of the Combinations of Gemigliptin/Metformin HCl Extended Release 50/1000mg(25/500mg x 2 Tablets) in Comparison to Each Component Administered Alone

NCT03355014 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

70

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Male Volunteers

Interventions

DRUG: Combination of gemigliptin/metformin HCl sustained release 50/1000mg
DRUG: Coadministration of gemigliptin 50mg and metformin HCl extended release 1000mg

Sponsor

LG Chem